Described herein are pharmaceutical packaging methods which stop oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-delicate medicines, this sort of methods including a syringe having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with very lower permeability to oxygen and comprises